Beauchamp, T. L. and J. F. Childress. 1994.
Principles of Biomedical Ethics.
New York /
Oxford: Oxford University Press.
Billings, J. A. and S. Block, ”Palliative care in undergraduate medical education. Status report
and future directions,” JAMA 278 (9): 733-738 (1997).
Bruera, E. et al., ”The Edmonton Symptom Assessment System (ESAS): a simple method for the
assessment of palliative care patients,”
J.Palliat.Care
7 (2): 6-9 (1991).
Clark,D. and M.Wright. Transitions in end of life care. Hospice and related developments in
Eastern Europe and Central Asia. 2002. Sheffield, University of Sheffield.
Crigger, B. J., ”Declaration of Helsinki revised,”
IRB. 22
(5): 10-11 (2000).
Cummings, I. 1998. The interdisiplinary team.
In Oxford Textbook of Palliative Medicine.
Edited
by G. W. Hanks, D Doyle, and N. MacDonald. Oxford / New York / Tokyo: Oxford University
Press.
Doyle, D, G. W. Hanks, and N. eds MacDonald. 1998.
Oxford Textbook of Palliative Care.
2nd
ed. Oxford / New York / Tokyo: Oxford University Press.
Elsey, B. and J. McIntyre, ”Assessing a support and learning network for palliative care workers
in a country area of South Australia,”
Aust.J.Rural.Health
4 (3): 159-164 (1996).
Field, M. J. and C. K. eds Cassell. 1997.
Approaching death. Improving care at the end of life.
Washington DC: National Academy Press.
Foley, K. M., ”Misconceptions and controversies regarding the use of opioids in cancer pain,”
Anticancer Drugs
6 Suppl 3: 4-13 (1995).
Foley, K. M., ”Controlling the pain of cancer,”
Sci.Am.
275 (3): 164-165 (1996).
Furst,C.J. 2000. ”Perspectives on palliative care: Sweden.”
Support Cancer Care.
8:441-443.
Grande, G. E. and C. J. Todd, ”Why are trials in palliative care so difficult?,”
Palliat.Med.
14
(1): 69-74 (2000).
Hanks, G. W. et al., ”Morphine and alternative opioids in cancer pain: the EAPC
recommendations,”
Br.J.Cancer
84 (5): 587-593 (2001).
Hardy, J. R., ”Placebo-controlled trials in palliative care: the argument for,”
Palliat.Med.
11 (5):
415-418 (1997).
87
CM(2003)130
